Anaplastic thyroid cancer

Below you will find more information about Anaplastic thyroid cancer from Medigest. If you believe that you are suffering from any of the symptoms of Anaplastic thyroid cancer it is important that you obtain an accurate diagnosis from a medical professional to ensure that you obtain the correct medication or treatment for your condition. There are medical conditions that carry similar symptoms associated with Anaplastic thyroid cancer and therefore the information provided by Medigest is offered as a guideline only and should never be used in preference to seeking professional medical advice. The information relating to Anaplastic thyroid cancer comes from a third party source and Medigest will not be held liable for any inaccuracies relating to the information shown.

Definition

Anaplastic thyroid cancer is a type of thyroid cancer that has an extremely poor prognosis with only 14% survival rate. This disease is known for its aggressive behavior and fatal resistance to available cancer treatments. Anaplastic thyroid cancer quickly invades surrounding tissues.

Treatment

Unlike other types of thyroid cancer, Anaplastic thyroid cancer is highly unlikely to be cured by surgery or other types of treatments. Anaplastic thyroid cancer cannot be removed by surgery because of its high propensity for affecting surrounding tissues. However, palliative treatments are available and may consist of radiation therapy combined with chemotherapy. New studies show that TNF-related Apoptosis Induced Ligand (TRAIL) and Bortezomib show positive results against Anaplastic thyroid cancer. However, more clinical tests outside the lab are still needed to confirm its effectiveness before it can be used for chemotherapy. The best treatment available for Anaplastic thyroid cancer is early detection and surgery, which is then followed by chemotherapy and radiotherapy for a larger chance of survival.

Discuss Anaplastic thyroid cancer in our forums

Discuss Anaplastic thyroid cancer with other members of Medigest in our forums.